Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
incobotulinumtoxinA
|
| gptkbp:approvalYear |
2010
|
| gptkbp:ATCCode |
M03AX01
|
| gptkbp:contraindication |
hypersensitivity to botulinum toxin
infection at injection site |
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
lyophilized powder
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xeomin
|
| gptkbp:indication |
chronic sialorrhea
upper limb spasticity |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merz_Pharma
|
| gptkbp:mechanismOfAction |
blocks neuromuscular transmission by inhibiting acetylcholine release
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
headache
muscle weakness injection site pain eyelid ptosis |
| gptkbp:similarTo |
gptkb:Botox
gptkb:Dysport |
| gptkbp:storage |
refrigeration not required before reconstitution
|
| gptkbp:usedFor |
treatment of blepharospasm
treatment of cervical dystonia treatment of glabellar lines |
| gptkbp:bfsParent |
gptkb:Botulinum_toxin
|
| gptkbp:bfsLayer |
6
|